Thomas Loewald Net Worth

The estimated Net Worth of Thomas W Loewald is at least $7.86 Million dollars as of 20 August 2019. Mr. Loewald owns over 20,000 units of Harvard Bioscience stock worth over $292,056 and over the last 13 years he sold HBIO stock worth over $7,431,483. In addition, he makes $136,501 as Independent Director at Harvard Bioscience.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr. Loewald HBIO stock SEC Form 4 insiders trading

Thomas has made over 24 trades of the Harvard Bioscience stock since 2012, according to the Form 4 filled with the SEC. Most recently he bought 20,000 units of HBIO stock worth $50,600 on 20 August 2019.

The largest trade he's ever made was exercising 22,437 units of Harvard Bioscience stock on 6 February 2014 worth over $1,110,407. On average, Thomas trades about 2,903 units every 39 days since 2012. As of 20 August 2019 he still owns at least 103,200 units of Harvard Bioscience stock.

You can see the complete history of Mr. Loewald stock trades at the bottom of the page.

Thomas Loewald biography

Thomas W. Loewald serves as Independent Director of the Company. Mr. Loewald has served as President of the Flexible Packaging Division of ProAmpac, a private-equity owned flexible packaging company. Prior to that, he served as Senior Vice President and Chief Commercial Officer of Thermo Fisher Scientific, a multinational biotechnology product development company. He previously worked in various roles of Thermo Fisher Scientific from 2002 to 2016. Prior to Thermo Fisher, Mr. Loewald led sales, marketing, and customer service for the adhesives division of Tyco International from 1998 to 2002. Prior to Tyco, Tom held a series of roles with General Electric’s Plastics and Materials businesses. Mr. Loewald holds a B.A. in economics from Middlebury College and an M.B.A. in business administration from Dartmouth College.

What is the salary of Thomas Loewald?

As the Independent Director of Harvard Bioscience, the total compensation of Thomas Loewald at Harvard Bioscience is $136,501. There are 8 executives at Harvard Bioscience getting paid more, with James Green having the highest compensation of $2,422,600.

How old is Thomas Loewald?

Thomas Loewald is 57, he's been the Independent Director of Harvard Bioscience since 2017. There are 6 older and 5 younger executives at Harvard Bioscience. The oldest executive at Harvard Bioscience Inc. is John Kennedy, 71, who is the Independent Director.

What's Thomas Loewald's mailing address?

Thomas's mailing address filed with the SEC is C/O HARVARD BIOSCIENCE, INC., 84 OCTOBER HILL RD., HOLLISTON, MA, 01746.

Insiders trading at Harvard Bioscience

Over the last 21 years, insiders at Harvard Bioscience have traded over $10,145,146 worth of Harvard Bioscience stock and bought 754,658 units worth $2,380,232 . The most active insiders traders include Earl R Lewis, Bertrand Loy, and David Green. On average, Harvard Bioscience executives and independent directors trade stock every 43 days with the average trade being worth of $182,054. The most recent stock trade was executed by James W Green on 13 June 2024, trading 10,000 units of HBIO stock currently worth $29,100.

What does Harvard Bioscience do?

harvard bioscience is a global developer, manufacturer and marketer of a broad range of specialized products, primarily apparatus and scientific instruments used to advance life science research at pharmaceutical and biotechnology companies, universities and government laboratories worldwide. we sell our products to thousands of researchers in over 100 countries through our full-line catalog (and various other specialty catalogs), our websites, and through distributors, including ge healthcare, thermo fisher scientific inc., and vwr. we have sales and manufacturing operations in the united states, the united kingdom, germany, and spain and sales facilities in france and canada.

Complete history of Mr. Loewald stock trades at Harvard Bioscience and Thermo Fisher Scientific

Harvard Bioscience executives and stock owners

Harvard Bioscience executives and other stock owners filed with the SEC include:

• James Green,
  Chairman of the Board, President, Chief Executive Officer
• James W. Green,
  Pres, CEO & Chairman
• Kenneth Fletcher Olson,
  Chief Operating Officer
• Michael A. Rossi,
  Chief Financial Officer
• Michael Rossi,
  Chief Financial Officer
• Bertrand Loy,
  Lead Independent Director
• John Kennedy,
  Independent Director
• Alan Edrick,
  Independent Director
• Thomas Loewald,
  Independent Director
• Katherine Eade,
  Independent Director
• Susan Steele,
  Independent Director
• Kenneth Olson,
  Vice President, General Manager - Data Sciences International
• David Sirois,
  Director of Corp. Accounting & SEC Reporting
• Jacques Coumans Ph.D.,
  Chief Marketing Officer
• David Green,
  President
• Earl R Lewis,
  Director
• Robert E. Gagnon,
  Chief Financial Officer
• Neal J Harte,
  Director
• George Uveges,
  Director
• Jeffrey Duchemin,
  Chief Executive Officer
• Yong Sun,
  VP - Strategic Marketing
• Kamalam Unninayar,
  Chief Financial Officer
• David L Strack,
  President of Subsidiary
• Chane Graziano,
  Chief Executive Officer
• Robert A Dishman,
  Director
• Yoav Sibony,
  VP - Global Sales
• Thomas Mc Naughton,
  Chief Financial Officer
• Mark A Norige,
  Chief Operating Officer
• Paul Bailey,
  Vice President Finance
• Bryce Anthony Chicoyne,
  Chief Financial Officer
• Advisors Llc Nelson Kerry S...,
  
• Limited Partnership Hso,
  10% owner
• Susan M Luscinski,
  Chief Financial Officer
• Yash Singh,
  Executive Vice President
• Jennifer Cote,
  Chief Financial Officer